TRANSITION, SEPARATION AND RELEASE OF CLAIMS AGREEMENTTransition, Separation and Release of Claims Agreement • March 2nd, 2022 • Schrodinger, Inc. • Pharmaceutical preparations • New York
This Transition, Separation and Release of Claims Agreement (the “Agreement”) is entered into by and between Schrödinger, Inc. (the “Company”) and Joel Lebowitz (“Executive”) (together, the “Parties”).
CONSULTING AGREEMENTConsulting Agreement • March 2nd, 2022 • Schrodinger, Inc. • Pharmaceutical preparations • New York
This Consulting Agreement (this “Agreement”) is entered into as of the Separation Date by and between Schrödinger, Inc. (the “Company”), and Joel Lebowitz (the “Consultant”), and will be effective as of the day immediately following the Separation Date (hereinafter, the “Consulting Effective Date”). Capitalized terms used but not defined herein have the meanings set forth in the Transition, Separation, and Release of Claims Agreement entered into by the Company and the Consultant (the “Separation Agreement”) to which this Agreement is attached as Attachment A.
